EIR Biomarin Pharmaceutical Feb 2020

Stephen Hansen FDA, Dipti Kalra FDA, Karen Montgomery FDA, Haley Seymour FDA, Dustin Tran FDA$595.00 - Available Now

FDA investigators audited the Biomarin Pharmaceutical - San Rafael, CA, United States facility and issued inspectional observation (via FDA 483) on 28 Feb 2020.

Product details

  • Category:
  • Inspection end: 28 Feb 2020
  • Location: San Rafael, United States
  • FEI: 3010446870
Add To Cart